• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

What’s Next in Vaccines? HIV, Malaria, MRSA, and 30 Other Vaccine Targets in the 2010-2016 Pipeline

$1,500.00 – $8,400.00

Clear
SKU: KLI2578515 Categories: Pharmaceuticals Market Research, Vaccines Market Reports Pages: 220
  • Description
  • Table of Contents
  • Latest reports

Description

The global market for human vaccines has experienced strong growth in the past few years, and R&D departments at many pharmaceutical companies are working on new prophylactics, some of which may see near-term marketing. What illnesses may see a vaccine option in the coming years? Which vaccines will have the most successful business model? Who are the major companies in this market, and possible new entrants? What can current vaccine success stories tell us about the future of the vaccine market? This Kalorama Information report What’s Next in Vaccines? examines and estimates the market for vaccines that have yet to be launched, including the following target areas:

 

  • Addiction
  • Allergy
  • Alzheimer’s Disease
  • Anthrax
  • Asthma
  • Campylobacter Infection
  • Chlamydia
  • Croup
  • Dengue Fever
  • Diabetes
  • Ebola
  • Epstein-Barr Virus
  • Enterotoxigenic Escherichia coli
  • Helicobacter Pylori
  • Hepatitis
  • Herpesvirus
  • Hookworm
  • Hypertension
  • HIV/AIDS
  • Leishmaniasis
  • Malaria
  • MRSA Infection
  • Multiple Sclerosis
  • Obesity
  • Parainfluenza Virus Type 3
  • Parkinson’s Disease
  • Plague
  • Respiratory Syncytial Virus
  • Ross River Virus
  • Shigellosis
  • Smoking
  • Stroke
  • Tuberculosis
  • West Nile Virus

 

 

Some of these vaccines may see success; some could be the blockbusters of the future. For marketers and industry watchers a knowledge of all of the potential vaccines will be important to understand how pharma is seeking to renew bottom line with aggressive prophylactic strategies, and who the winners and losers in the near future may be.
Alison Sahoo has looked at the vaccine market three times in as many years for Kalorama Information, and in this report applies a knowledge of what companies have done in the past to potential efforts.

There are a number of trends that will impact the industry that market watchers will want to know about, and Kalorama Information has covered these trends; including: New Vaccine Technologies, DNA Vaccination, Innovative Delivery Systems, Edible Vaccines, Vaccine Patches, Funding Shortfalls. The report also discusses vaccine manufacturing methods and the approval process. In addition, the report focuses on the emerging vaccine activities of the following companies

  • Acambis plc
  • ACE BioSciences
  • AFFiRiS
  • ALK-Abello A/S
  • Allergy Therapeutics
  • Bavarian Nordic A/S
  • Baxter Healthcare
  • Celldex Therapeutics
  • Crucell
  • Cytos Biotechnology
  • GlaxoSmithKline
  • Hawaii Biotech
  • Intercell
  • Medimmune
  • Merck & Co. Inc
  • Mymetics
  • Nabi Biopharmaceuticals
  • Novartis
  • Opexa Therapeutics
  • Paladin Labs
  • Sanofi Pasteur

 

This report provides forecasted revenues for products in development out to 2020. The report does not does not cover indication expansions of existing vaccine products, nor does it cover vaccines for which products currently exist and are widely available, but may need improvement. Development of vaccines that incorporate new

production methods (such as the migration of chicken eggs to mammal, yeast or other cells) is also excluded. Cancer vaccines are excluded as Kalorama has an entire report on this topic.

Sales estimates for each market segment represent global revenues and are expressed in current dollars. Information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

Scope and Methodology

Overview

Emerging Vaccines and Forecasts

The Global Market for Emerging Vaccines

CHAPTER TWO: INTRODUCTION TO VACCINES

A Brief History: The Development of Vaccines

The Immune Response

Mechanism of Action

Types of Vaccines

Attenuated (Weakened) Live Viruses

Killed (Inactivated) Viruses

Toxoid Vaccines

Genetically Engineered/Modified Vaccines

Bacteria-Based Vaccines

Subunit Vaccines

Conjugate Vaccines

DNA Vaccination

Vaccine Approval Process

Trends Driving the Vaccines Market

CHAPTER THREE: EMERGING VACCINES

Introduction

Emerging Vaccines by Disease Area

Addiction

Smoking

Allergy

Alzheimer’s Disease

Anthrax

Asthma

Campylobacter Infection

Chlamydia

Croup

Dengue Fever

Diabetes

Ebola

Epstein-Barr Virus

Enterotoxigenic Escherichia coli

Heart Attack

Helicobacter Pylori

Hepatitis

Hepatitis C

Hepatitis E

Herpesvirus

Hookworm

Hypertension

HIV/AIDS

Leishmaniasis

Malaria

MRSA Infection

Multiple Sclerosis

Obesity

Parainfluenza Virus Type 3

Parkinson’s Disease

Plague

Respiratory Syncytial Virus

Ross River Virus

Shigellosis

Stroke

Tuberculosis

West Nile Virus

CHAPTER FOUR: EMERGING VACCINES MARKET FORECAST

Global Market for Emerging Vaccines

Emerging Vaccines Market Segment Forecasts

Addiction

Allergies

Alzheimer’s Disease

Anthrax

Asthma

Campylobacter Infection

Chlamydia

Croup

Dengue Fever

Diabetes

Ebola

EBV Infection

ETEC Infection

Heart Attack

  1. Pylori Infection

Hepatitis C and E

Herpesvirus Infection

Hookworm

Hypertension

HIV/AIDS

Leishmaniasis

Malaria

MRSA Infection

Multiple Sclerosis

Obesity

PIV-3 Infection

Parkinson’s Disease

Plague

RSV Infection

Ross River Virus Infection

Shigellosis

Stroke

Tuberculosis

West Nile Virus

CHAPTER FIVE: ISSUES AND TRENDS

New Vaccine Technologies

DNA Vaccination

Innovative Delivery Systems

Edible Vaccines

Mucosal Delivery

Intranasal Delivery

Vaccine Patches

Funding Shortfalls

CHAPTER SIX: COMPANY PROFILES

Acambis plc

History and Lines of Business

Emerging Vaccine Activities

Financial Information

ACE BioSciences

History and Lines of Business

Emerging Vaccine Activities

Financial Information

AFFiRiS

History and Lines of Business

Emerging Vaccine Activities

Financial Information

ALK-Abello A/S

History and Lines of Business

Emerging Vaccine Activities

Financial Information

Allergy Therapeutics

History and Lines of Business

Emerging Vaccine Activities

Financial Information

Bavarian Nordic A/S

History and Lines of Business

Emerging Vaccine Activities

Financial Information

Baxter Healthcare

History and Lines of Business

Emerging Vaccine Activities

Financial Information

Celldex Therapeutics

History and Lines of Business

Emerging Vaccine Activities

Financial Information

Crucell

History and Lines of Business

Emerging Vaccine Activities

Financial Information

Cytos Biotechnology

History and Lines of Business

Emerging Vaccine Activities

Financial

GlaxoSmithKline

History and Lines of Business

Emerging Vaccine Activities

Financial Information

Hawaii Biotech

History and Lines of Business

Emerging Vaccine Products

Financial Information

Intercell

History and Lines of Business

Emerging Vaccine Products

Financial Information

Medimmune

History and Lines of Business

Emerging Vaccine Products

Financial Information

Merck & Co. Inc

History and Lines of Business

Emerging Vaccine Activities

Financial Information

Mymetics

History and Lines of Business

Emerging Vaccine Products

Financial Information

Nabi Biopharmaceuticals

History and Lines of Business

Emerging Vaccine Activities

Financial Information

Novartis

History and Lines of Business

Emerging Vaccine Activities

Financial Information

Opexa Therapeutics

History and Lines of Business

Emerging Vaccine Activities

Financial Information

Paladin Labs

History and Lines of Business

Emerging Vaccine Activities

Financial Information

Sanofi Pasteur

History and Lines of Business

Emerging Vaccine Activities

Financial Information

Appendix

Company Directory

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Table 1-1: Status of Emerging Vaccines by Disease

CHAPTER TWO: INTRODUCTION TO VACCINES

Table 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2008

Table 2-2: Vaccine-Preventable Diseases, December 2009

Table 2-3: VAERS Table of Reportable Events Following Vaccination

CHAPTER THREE: EMERGING VACCINES

Figure 3-1: Global Prevalence of Conditions Addressed by Emerging Vaccines

Figure 3-2: Comparative Mortality, Symptom Severity and Treatment Availability for Conditions Addressed by Emerging Vaccines

Table 3-1: Emerging Vaccines by Disease and Stage of Testing

Figure 3-3: Comparative Severity Ranking of Addiction

Figure 3-4: Comparative Severity Ranking of Allergy

Figure 3-5: Comparative Severity Ranking of Alzheimer’s Disease

Figure 3-6: Comparative Severity Ranking of Anthrax

Figure 3-7: Comparative Severity Ranking of Asthma

Figure 3-8: Comparative Severity Ranking of Campylobacter Infection

Figure 3-9: Comparative Severity Ranking of Chlamydia

Figure 3-10: Comparative Severity Ranking of Croup

Figure 3-10: Comparative Severity Ranking of Dengue Fever

Figure 3-12: Comparative Severity Ranking of Diabetes

Figure 3-13: Comparative Severity Ranking of Ebola

Figure 3-14: Comparative Severity Ranking of EBV

Figure 3-15: Comparative Severity Ranking of ETEC

Figure 3-16: Comparative Severity Ranking of Heart Attack

Figure 3-17: Comparative Severity Ranking of H. Pylori Infection

Figure 3-10: Comparative Severity Ranking of Hepatitis C and E

Figure 3-19: Comparative Severity Ranking of Herpesvirus Infection

Figure 3-20: Comparative Severity Ranking of Hookworm

Figure 3-21: Comparative Severity Ranking of Hypertension

Figure 3-10: Comparative Severity Ranking of HIV/AIDS

Figure 3-23: Comparative Severity Ranking of Leishmaniasis

Figure 3-24: Comparative Severity Ranking of Malaria

Figure 3-25: Comparative Severity Ranking of MRSA Infection

Figure 3-26: Comparative Severity Ranking of Multiple Sclerosis

Figure 3-27: Comparative Severity Ranking of Obesity

Figure 3-28: Comparative Severity Ranking of PIV-3 Infection

Figure 3-29: Comparative Severity Ranking of Parkinson’s Disease

Figure 3-30: Comparative Severity Ranking of Plague

Figure 3-31: Comparative Severity Ranking of RSV Infection

Figure 3-32: Comparative Severity Ranking of Ross River Virus Infection

Figure 3-33: Comparative Severity Ranking of Shigellosis

Figure 3-34: Comparative Severity Ranking of Stroke

Figure 3-35: Comparative Severity Ranking of Tuberculosis

Figure 3-36: Comparative Severity Ranking of West Nile Virus Infection

CHAPTER FOUR: EMERGING VACCINES MARKET FORECAST

Table 4-1: World Market for Emerging Vaccines by Type, 2009-2020

Table 4-2: World Market for Emerging Vaccines by Type, 2009-2020

Table 4-3: World Addiction Vaccine Market 2009-2020

Table 4-4: World Allergy Vaccine Market 2009-2020

Table 4-5: World Alzheimer’s Disease Vaccine Market 2009-2020

Table 4-6: World Anthrax Vaccine Market 2009-2020

Table 4-7: World Asthma Vaccine Market 2009-2020

Table 4-8: World Campylobacter Infection Vaccine Market 2009-2020

Table 4-9: World Chlamydia Vaccine Market 2009-2020

Table 4-10: World Croup Vaccine Market 2009-2020

Table 4-11: World Dengue Fever Vaccine Market 2009-2020

Table 4-12: World Diabetes Vaccine Market 2009-2020

Table 4-13: World Ebola Vaccine Market 2009-2020

Table 4-14: World EBVVaccine Market 2009-2020

Table 4-15: World ETECVaccine Market 2009-2020

Table 4-16: World Heart Attack Vaccine Market 2009-2020

Table 4-17: World H. Pylori Vaccine Market 2009-2020

Table 4-18: World Hepatitis C and E Vaccine Market 2009-2020

Table 4-19: World Herpesvirus Vaccine Market 2009-2020

Table 4-20: World Hookworm Vaccine Market 2009-2020

Table 4-21: World Hypertension Vaccine Market 2009-2020

Table 4-22: World HIV/AIDS Vaccine Market 2009-2020

Table 4-23: World Leishmaniasis Vaccine Market 2009-2020

Table 4-24: World Malaria Vaccine Market 2009-2020

Table 4-25: World MRSA Vaccine Market 2009-2020

Table 4-26: World Multiple Sclerosis Vaccine Market 2009-2020

Table 4-27: World Obesity Vaccine Market 2009-2020

Table 4-28: World PIV-3 Vaccine Market 2009-2020

Table 4-29: World Parkinson’s Disease Vaccine Market 2009-2020

Table 4-30: World Plague Vaccine Market 2009-2020

Table 4-31: World RSV Vaccine Market 2009-2020

Table 4-32: World Ross River Virus Vaccine Market 2009-2020

Table 4-33: World Shigellosis Vaccine Market 2009-2020

Table 4-34: World Stroke Vaccine Market 2009-2020

Table 4-35: World Tuberculosis Vaccine Market 2009-2020

Table 4-36: World West Nile Virus Vaccine Market 2009-2020

    Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
    April 11, 2025
    Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
    February 13, 2025
    Cell and Gene Therapy Deals Analysis, 2021-2024
    June 3, 2024
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
    April 30, 2024

Related products

  • Placeholder image

    Women’s Health: Worldwide Prescription Drug Markets – 3rd Edition

    $2,812.00 – $5,625.00
  • Placeholder image

    Outsourcing in Drug Development – The Contract Research Market from Preclinical to Phase III

    $3,500.00 – $7,000.00
  • Placeholder image

    Cardiovascular Disease: The 45 Market in the United States for Drugs and Medical Devices

    $2,995.00 – $5,990.00
  • Placeholder image

    Worldwide Market for Prescription Dermatological Drugs – 4th Edition, The

    $3,500.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis...Global Market for Medical Devices
Scroll to top